Gene therapy of lung cancer
Authors:
- 18 September 2003
- journal article
- review article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 21 (3) , 196-204
Abstract
It is estimated that there will be 157,200 deaths from lung cancer in 2003. Current regimens of surgery, chemotherapy and radiation have not significantly changed overall 5-year survival rates for this disease. Thanks to intensive molecular studies over the last three decades, new targets for treatment have been identified, including replacement of tumor suppressor genes, prevention of angiogenesis and tumor growth, and regulation of programmed cell death. Promising advances have been made but obstacles still abound before effective use of these strategies at the patient bedside can occur. One area of concentration lies in developing more accurate and complete delivery of the therapeutic constructs. In the evolution of gene therapy approaches, from beginning theory to translational research, investigators in thoracic malignancies have played a leading role, utilizing a number of methods and delivery vehicles. The objective of this review is to discuss some of the major molecular targets available for manipulation in lung cancer, describe vectors and techniques currently used by thoracic researchers to deliver therapy, and provide the p53 model as an example of progression from bench research to clinical treatment.Keywords
This publication has 52 references indexed in Scilit:
- Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivoOncogene, 2002
- HER‐2/neuoverexpression in patients with radically resected nonsmall cell lung carcinomaCancer, 2002
- Melanoma Differentiation Associated Gene-7 (mda-7): A Novel Anti-Tumor Gene for Cancer Gene TherapyMolecular Medicine, 2001
- Over-expression of p27kip1 induces growth arrest and apoptosis mediated by changes of pRb expression in lung cancer cell linesInternational Journal of Cancer, 2000
- Molecular abnormalities in lung cancer.Journal of Clinical Oncology, 1998
- Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cellsOncogene, 1998
- Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective StudyJNCI: Journal of the National Cancer Institute, 1997
- An Early History of Gene Transfer and TherapyHuman Gene Therapy, 1994
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983